Tox study completion will certainly be welcome news and another significant box ticked, but even if it arrives early, this news alone would mean that RC220 is still just sitting there on the same shelf that it currently is.
Therefore I really hope that we soon start to hear significant news regarding the upcoming trial(s), of which we've heard basically nothing so far... trial design, site locations, investigators/doctors involved, CRO selection/appointments, ethics and governance approval submissions, IND/international expansion plans, etc. It's no wonder that @RaceOncology is busy at the moment because all of these activities must be ongoing concurrently and hopefully nearing completion and soon able to be shared.
We've only got 34 business days left until the end of the quarter now... can Race show us in that time that they're ready to hit the ground running once RC220 is legally able to be given to prospective patients?
General Comments / Chat, page-10903
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.020(1.10%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $222.5K | 123.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1390 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 200 | 1 |
View Market Depth
| Last trade - 12.28pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |